Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Blood Advances|April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALLGaia Gentile, Teresa Poggio, Antonella Catalano, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
The Journal of Pathology|November 25, 2024
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartmentThien-Ly Julia Dinh, Manuel Rogg, Miguel Cosenza-Contreras, et al.
The New England Journal of Medicine|January 22, 2025
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal CancerJens Hoeppner, Thomas Brunner, Claudia Schmoor, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
British Journal of Cancer|August 10, 2016
L1CAM expression in endometrial carcinomas: an ENITEC collaboration studyLouis Jm van der Putten, Nicole Cm Visser, Koen van de Vijver, et al.
Journal of the National Cancer Institute|April 10, 2015
Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancerEduardo Pérez-Gómez, Clara Andradas, Sandra Blasco-Benito, et al.
Journal of Hepatology|April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinomaMaryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic CancerJoan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
Human Pathology|May 6, 2019
Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration studyNicole C M Visser, Louis J M van der Putten, Alex van Egerschot, et al.
Pageof 17